Physician

Tina Ashley Khair, D.O.

According to 2025 Medicare claims, Tina Khair, D.O. (NPI: 1730338112) practices hematology/oncology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is SATISH A SHAH MD PC (NPI: 1982734976; TIN: 23-2586060) and primary practice location at 17331-1587.

Khair's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 539 traditional Medicare patients, billed 168,868 HCPCS/CPT codes, and received $3,482,529 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,905 prescription claims across 258 beneficiaries totaling $8,460,422 in drug costs, led by Lenalidomide (Lenalidomide). 2021 DME data shows 96 claims. Open Payments data shows 14 records totaling $317. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,269,522 to $3,482,529. Similarly, Part D prescription costs have moved sharply higher in recent years, from $559,628 to $8,460,422. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	394	124,589	$1,269,522
2016	342	132,606	$1,532,821
2017	348	134,815	$1,635,751
2018	392	135,018	$1,865,487
2019	395	154,120	$2,229,203
2020	428	168,867	$2,606,800
2021	480	200,113	$1,969,741
2022	458	171,685	$2,830,369
2023	528	170,561	$3,342,047
2024	539	168,868	$3,482,529

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	112	630	$559,628
2016	108	902	$1,069,544
2017	119	831	$1,171,821
2018	147	978	$1,637,303
2019	159	1,160	$2,732,623
2020	178	1,420	$3,590,001
2021	198	1,991	$6,559,392
2022	199	1,589	$6,302,940
2023	225	1,587	$6,243,142
2024	258	1,905	$8,460,422

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	37	$3,656
2016	N/R	25	$17,486
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	96	$6,226
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	391	1,550	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	91	108	$62
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	98	386	$49
36415	Insertion of needle into vein for collection of blood sample	469	2,154	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	461	2,285	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	55	1,540	$804,011
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	65	1,218	$679,500
Keytruda	Pembrolizumab	54	1,134	$603,279
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	52	1,543	$425,380
Ibrance	Palbociclib	27	756	$401,751

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$317	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tina Ashley Khair, D.O.?

Tedicare shows public-source Medicare data for Tina Ashley Khair, D.O. (NPI 1730338112), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tina Ashley Khair, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tina Ashley Khair, D.O.?

Tina Ashley Khair, D.O. is linked to SATISH A SHAH MD PC (billing NPI 1982734976) in the available physician profile data.

Does Tina Ashley Khair, D.O. have Open Payments data?

Tina Ashley Khair, D.O. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.